PIXIUM VISION overview

Pixium Vision announces the opening of safeguard proceedings Paris, France, October 9, 202 3 – 19:00 (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX) (the “ Company ”), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces the opening today of safeguard proceedings by the Commercial Court of Paris. Indeed, despite all the efforts made in the research of financing...

Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing shares Bridge financing: 3 million Euro convertible shareholders’ loan from Bpifrance and Sofinnova to extend c ash runway to the end of November 2023 Publication of half-year financial statements postponed to September 2023 Reverse stock split: implementation of a reverse stock split process - allocation of 1 new ordinary share...

Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing facility Paris, France, Ju ly 11 , 202 3 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641; Mnemo: ALPIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces today that it successfully negotiated an extension of the maturity date,...

Annual Meeting of Shareholders June 1 3 , 202 3 Availability of preparatory documents Paris, France , May 2 4 , 202 3 – 19:00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, informs its shareholders that its Annual Meeting of the Company will be held on June 13, 2023, at 2.00 pm CET at the headquarter of Pixium Vision, 74 rue du...

Pixium Vision announces its consolidated financial statements for the financial year 202 2 and the consolidated cash balance for March 31 , 2023 Paris, April 21 , 202 3 – 7.00 a.m. CET - Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, announces that the consolidated financial statements for the year 2022 were approved by Pixium Vision’s...